Figs. S1-S4
Supplemental Tables:  Tables S1-S3 Supplemental Methods: spliceosomes (formed on 32 P-labeled wild-type actin pre-mRNA) incubated with Prp2 and Spp2 in the absence (black, B act ) or presence (grey, B*) of 1 mM UTP. Radioactivity contained in each fraction was determined by Cherenkov counting. The percent of total radioactivity present in each gradient fraction is plotted. 10-30% v/v glycerol gradients containing 75 mM KCl were loaded with 400 µl sample and centrifuged for 2 h at 60000 rpm in a TH660 rotor (Sorvall). . 5 ). Spp2 does not enable Prp2 to unwind dsRNA. RNA unwinding assays were performed with 0.25 nM U4/U6 snRNA duplex (U6 was 32 P-labeled) and 50 nM Prp2 or Prp22. When indicated 4 µM Spp2 was added to the reaction. Unwinding reactions were pre-incubated for 10 min at 35° C and initiated by the addition of 3 mM ATP. At the indicated time points, 5 µl aliquots of the unwinding reaction were withdrawn. Samples were separated by 8 % non-denaturing PAGE and visualized by autoradiography. Table  S2 ). Proteins were identified by LC-MSMS after separation by PAGE. The table contains information about the concentration (in fmoles) of each complex analyzed by mass spectrometry. The table shows the S. cerevisiae protein, systematic gene name and the calculated molecular weight of the (S. cerevisiae) protein in kDa. The fourth column contains the name of the human protein to aid comparison with previous studies of human spliceosomal complexes. Proteins are grouped in organisational and/or functional subgroups. Note that Cwc24, Cwc27 and the RES complex proteins are equally represented in the absence or presence of ATP, while they are displaced from a catalytically activated Act-wt B* complex (Warkocki et al. 2009 ).
.
Supplemental methods

Purification of spliceosomes
Preparative purifications of the B act ΔPrp2 or B act ΔPrp2 ΔSpp2 spliceosome were performed as described previously (Warkocki et al. 2009 ). Briefly, in vitro splicing reactions with 1.7-2 nM pre-mRNA (containing trace 32 P-labeled pre-mRNA, ca. 20-100 cpm/fmole) and 40% v/v heat-treated (35 o C, 30 min) yeast whole-cell extract from prp2-1 cells [strain 3.2. AID; alpha, ade2, his3, ura3 , carrying a G360D mutation in Prp2; (Yean and Lin 1991) ] were incubated for 30-40 min at 23 o C. The reactions were layered on 10-30% v/v glycerol gradients (20 mM Hepes-KOH pH 7.9, 150 mM KCl, 1.5 mM MgCl 2 , 0.01% NP40; up to 6 ml of splicing reaction were layered onto one gradient, total volume was 36 ml) and centrifuged in a SureSpin rotor (Kendro) at 23000 rpm at 4 o C for 14h. Gradients were fractionated manually into 24 fractions from top to bottom. Spliceosomes in fractions 15-20 were pooled and affinity selected on 0.6 ml amylose resin (NEB) in 10 ml columns (BioRad). Beads were washed with 20 ml GK150 or GK75 buffer (150 or 75 mM KCl, 20 mM Hepes-KOH pH 7.9, 1.5 mM MgCl 2 , 5% v/v glycerol, 0.01% NP40) as indicated. Spliceosomes were eluted with 0.6 ml of GK75 containing 12 mM maltose. The amounts and molarity of the eluted spliceosomes was estimated based on the specific activity of the pre-mRNA and the cpms determined by Cherenkov counting.
Reconstitution of Prp2 activity in vitro
Affinity purified B act ΔPrp2 ΔSpp2 spliceosomes (Fig. 3A) , were incubated in the presence of 0.12 U/µl RNAsin (Promega), Prp2 with or without Spp2 (both 40 nM), and 1 mM ATP for 30 min at 23 o C. 400 µl of the sample were loaded on a 10-30% v/v glycerol gradient in GK75 buffer and centrifuged for 2 h at 60000 rpm at 4 o C in a TH660 rotor (Thermo Scientific). Gradients were fractionated manually into 24 fractions from top to bottom. Radioactivity in each fraction was measured by Cherenkov counting and plotted as percent of total radioactivity present in the gradient (including pelleted material).
Reconstitution of step 1 catalysis in vitro
The reconstitution reactions in Figs. S1 and 3 were assembled on ice and performed as described in (Warkocki et al. 2009 ). Briefly, purified spliceosomes (ca. 1 nM) were incubated in the presence of 0.12 U/µl RNAsin, with Cwc25, Prp2, Spp2 (each 40 nM) and ATP (1 mM) as indicated (or with increasing concentrations of ATP, CTP, GTP and UTP, Fig. S1A ) for 1 h at 23 o C. All reactions were stopped by addition of EDTA, SDS and proteinase K (10 mM, 0.2%, 0.2 mg/ml) and processed as described above for splicing in vitro. In Fig. 3B the spliceosomes were collected from peak fractions of glycerol gradients.
Splicing substrates
All pre-mRNAs were generated by run-off transcription in vitro with T7 RNA polymerase on PCR-amplified DNA templates of yeast actin pre-mRNA tagged with three MS2 stem-loops at the 5' end as described in ). The tagged transcripts contain 687 (wild-type) and 480 (ActΔ6) nucleotides. Radioactively body-labeled pre-mRNAs were produced in the presence of α 32 P UTP at concentrations that on average allowed incorporation of 1-1.2 32 P uridine residues per transcript. Transcripts were PAGE purified. The concentration and purity of unlabeled transcripts were estimated by measuring absorbance at 260 nm.
Production of site-specific labeled pre-mRNA and DNA splint-directed RNA ligation Site-specific labeled pre-mRNA was produced by ligation of RNA fragments prepared previously by site-specific cleavage of the pre-mRNA with DNA enzymes essentially as described by (Cameron and Uhlenbeck 1977; Silverman and Baum 2009) . RNA fragments were ligated by DNA splint directed RNA ligation essentially as described previously (Moore and Sharp 1992) .
Preparation of yeast whole-cell extract
The yeast cells prp2-1 (MATalpha, ade2, his3, ura3 ; kindly provided by Dr. Ren-Jang Lin), were grown to OD 600 = 5-6. The cells were harvested and washed with ice-cold water. Each 50 g of washed and pelleted cells were suspended in 45 ml AGK buffer (20 mM HEPES-KOH pH 7.9, 400 mM KCl, 1.5 mM MgCl 2 , 8% (v/v) glycerol) containing 1 mM DTT and protease inhibitors (Roche) and drops were frozen in liquid nitrogen. Frozen yeast-cell beads were ground and the resulting powder was thawed in a water bath at room temperature. The crude lysate was centrifuged twice at 4 °C in a SS34 rotor (Sorvall) at 17000 rpm for 30 min. The supernatant was then centrifuged for 1 h in a T647.5 rotor (Thermo Scientific) at 42000 rpm. The resulting cleared-lysate (middle phase, ca. 70% of total volume) was dialyzed twice in dialysis membranes (Spectrum, membrane cut-off 6-8 kDa) against 5 L of buffer D (20 mM HEPES-KOH pH 7.9, 50 mM KCl, 0.2 mM EDTA, 20% (v/v) glycerol, 0.5 mM DTT, 0.5 mM PMSF, 2 mM benzamidine) for 1 h 45 min-2 h or subjected to cross-flow dialysis (Sartorius Stedim Biotech). The dialysed extract was centrifuged in a SS34 rotor (Sorvall) for 10 min at 4°C, divided into aliquots, frozen in liquid nitrogen, and stored at -80°C.
Calculation of UTP hydrolysis
We calculated the fraction of UDP and UTP in a single aliquot on the basis of ImageQuant 5.1-reported intensities according to UDP=[UDP]/([UTP]+[UDP]) (1). The amount of hydrolyzed UTP (formed UDP) in fmol was calculated by multiplying (1) by the total amount of UTP in the test tube and 1000 (1)·(12 µl·100 pmol/µl)·(1000) (2). To obtain the number of UTP molecules hydrolyzed per Prp2 and the spliceosome (2) was divided by the amount of Prp2-bound spliceosomes in the test tube. To obtain the number of UTP molecules hydrolyzed exclusively by Prp2 in the presence of the spliceosome, we first subtracted from (2) the spliceosome-dependent background UTP hydrolysis estimated on the basis of linear regression from the sample lacking Prp2. Subsequently, the obtained value was divided by the amount of Prp2 in the test tube. 
